No label defined (Q28275393)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	No label defined	scientific article

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN (English)

0 references

1 reference

based on heuristic

inferred from title

object named as

S Bonini

4

0 references

3

object named as

L Bjermer

0 references

1 reference

ORCID Public Data File 2021

author name string

K H Carlsen

1

0 references

S D Anderson

2

0 references

V Brusasco

5

0 references

W Canonica

6

0 references

J Cummiskey

7

0 references

L Delgado

8

0 references

S R Del Giacco

9

0 references

F Drobnic

10

0 references

T Haahtela

11

0 references

K Larsson

12

0 references

P Palange

13

0 references

T Popov

14

0 references

P van Cauwenberge

15

0 references

language of work or name

0 references

publication date

May 2008

0 references

0 references

63

0 references

5

0 references

492-505

0 references

Characterization of within-subject responses to fluticasone and montelukast in childhood asthma

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2008.01663.X

21 April 2017

Effects of inhaled salbutamol in exercising non-asthmatic athletes

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2008.01663.X

21 April 2017

Nordic consensus report on asthma management. Nordic Asthma Consensus Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Bone mineral density and bone metabolism of prepubertal children with asthma after long-term treatment with inhaled corticosteroids.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

No effect of montelukast on asthma-like symptoms in elite ice hockey players

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Duration of Protection by Inhaled Salmeterol in Exercise-induced Asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Beta2-agonists and exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

General principles for systematic reviews and meta-analyses and a critique of a recent systematic review of long-acting beta-agonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Comparative efficacy of salbutamol, ipratropium, and cromoglycate in the prevention of bronchospasm induced by exercise and hyperosmolar challenges

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

The effect of formoterol inhalation on endurance performance in hypobaric conditions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Albuterol has no effect on diaphragmatic fatigue in humans.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Effects of salbutamol and caffeine ingestion on exercise metabolism and performance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

The effects of salmeterol on power output in nonasthmatic athletes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Acute formoterol administration has no ergogenic effect in nonasthmatic athletes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01663.X

21 January 2018

Identifiers

10.1111/J.1398-9995.2008.01663.X

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

release_hfadlbqiljbxxdzfhbpc7vom3i

1 reference

https://api.fatcat.wiki/v0/release/hfadlbqiljbxxdzfhbpc7vom3i

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28275393&oldid=1835573243"